Suppressive effects of co-stimulatory molecule expressions on mouse splenocytes by anti-allergic agents in vitro

Mediators of Inflammation

Volumn 9, Issue 2, 2000, Pages 69-75

  Ito, Jun Ichi ^a   Asano, Kazuhito ^a   Tryka, Elzbieta ^a,b   Kanai, Ken Ichi ^a   Yamamoto, Sumiko ^a   Hisamitsu, Tadashi ^a   Suzaki, Harumi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Anti allergic agent; Co stimulatory molecule; Expression; Inhibition; Mouse; Spleen cell

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CROMOGLYCATE DISODIUM; EPINASTINE; HEMOCYANIN;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CONCENTRATION RESPONSE; DRUG EFFECT; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ANIMALIA;

EID: 0033939993     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/096293500411523     Document Type: Article

References (35)

1. 1. Snapper JR. Inflammation and airway function: The asthma syndrome. Am Rev Respir Dis 1990:141:531-3.
2. 2. Kay AB. T lymphocytes and their products in atopic allergy and asthma. Int Arch Allergy Appl Immunol 1991:94:189-93.
3. 3. Corrigan CJ, Kay AB. T cells and cosinophils in the pathogenesis of asthma. Immunol Today 1992:13:501-6.
4. 4. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a co-stimulatory signalling pathway determines the out come of T cell antigen receptor occupancy. Annu Rev Immunol 1989:7:445-80.
5. 5. Robinson DS. T cell costimulation: a potential therapeutic target in asthma? Clin Exp Immunol 1998:28:788-90.
6. 6. Schwartz RH. Costimulation of T lymphocytes: The role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992:71:1065-8.
7. 7. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996:14:233-58.
8. 8. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996:184:1-8.
9. 9. Loh RKS, Jabara HH, Geha RS. Disodium cromoglycate inhibits Sν to Sε deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994:180:663-71.
10. 10. Worm M, Henz BM. Melecular regulation of human IgE synthesis. J Mol Med 1997:75:440-7.
11. 11. Podleski WK, Panaszek BA, Schmidt JL, Burrs RB. Inhibition of eosinophil degranulation by in a patients with milk allergy, manifested as bronchial asthma-an electron microscopic study. Agents Actions 1984:5:177-81.
12. 12. Tasaka K, Mio M, Okamoto M. Intracellular calcium release induced by histamine release and its inhibitory by some antiallergic drugs. Ann Allergy 1986:56:464-9.
13. 13. Yanagihara Y, Kasai H, Kawashima T, Shida T. Immunopharmacological studies on TBX, a new antiallergic drug. Jpn J Pharmacol 1988:48:91-6.
14. 14. Tasaka K, Akagi M, Izushi K, Aoki I. Antiallergic effect of epinastine: the elucidation of the mechanism. Pharmacometrics 1990:39:365-73.
15. 15. Morimoto C, Torimoto Y, Levinson G, et al. IF7, a novel cell surface molecule involved in helper function of CD4 cells. J Immunol 1989:143:3430-9.
16. 16. Kay AB. Role of T cells in asthma. Allergy Int 1997:46:73-82.
17. 17. Frew AJ. Cytokines, chemokines, T cells and allergy. Clin Exp Allergy 1996.26:2-4.
18. 18. Van Neerven RJJ, Van De Polo MM, Van Der Zee JS, et al. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy 1998:28:808-16.
19. 19. Riese RJ, Mitchell RN, Villadangos JA, et al. Cathepsin S activity regulates antigen presentation and immunity J Clin Invest 1998:101: 2351-63.
20. 20. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp Med 1992:175:353-60.
21. 21. Blazar BR, Taylor PA, Panoskaltsis-Mortari A, et al. Blocking of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 1997:158:29-39.
22. 22. Saito K, Sakurai J, Ohata J, et al. Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cells lacking CD28. J Immunol 1998:160:4225-31.
23. 23. Cayabyab M, Phillips JH, Lanier LL. CD40 preferentially co-stimulates activation of CD4+ T lymphocytes. J Immunol 1994:152:1523-31.
24. 24. Roy M, Aruffo A, Ledbetter J, et al. Studies on interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol 1995:25:596-603.
25. 25. Church M, Polosa R, Rimmer S. Cromolyn sodium and nedocromil sodium. Mast cell stabilizers, neuromodulators, or anti-inflammatory drugs? In: Kaliner MA, Barnes PJ, Persson CGA, eds Asthma. Its Pathology and Treatment. New York: Marcel Dekker, 1991, pp. 561-93.
26. 26. De Boer M, Kasran A, Kwekkeboom J, et al. Ligation of B7 with CD2H/ CTLA4 on T cells results in CD40 ligand expression, interleukin 4 secretion, and efficient help for antibody production by B cells. Eur J Immunol 1993; 23:3120-3125.
27. 27. Kawamura MS, Aiba S, Tagami H. The importance of CD54 and CD86 costimulation in T cells stimulated Candida albicans and Dermatophagoides farinae antigens in patients with atopic dermatitis. Arch Dermatol Res 1998; 290: 603-609.
28. 28. Kuchroo VK, Das MP, Brown JA, et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80: 707-718.
29. 29. Tsuyuki S. Tsuyuki J, Einsle K, Kopf M, Coyle AJ. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med 1997; 185: 1671-1679.
30. 30. Harris N, Peach R, Naemura J, et al. CD80 costimulation is essential for the induction of airway eosinophilia J Exp Med 1997; 185: 177-182.
31. 31. Nakajima H, Sano H, Nishimura S, Yoshida S, Iwamoto I. Role of vascular adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994; 179: 1145-1154.
32. 32. Spataro AC, Bosmann HB. Mechanism of action of disodium cromoglycate-mast cell calcium ion influx after a histamin-releasing stimulus. Biochem Pharmacol 1976:25:505-10.
33. 33. Akagi M, Mio M, Tasaka K, Kinima S. Histamine release inhibition and prevention of the decrease in membrane fluidity induced by certain antiallergic agents. Agents Actions 1983:12.149-53.
34. 34. Endres S, Fulle HJ, Sinha B, et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-α and interleukin-1β by human mononuclear cell. Immunology 1991:72:56-60.
35. 35. Shimozato T, Iwata M, Kawada H, Tamura N. Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3′5′-monophosphate levels, resulting in suppression of tumor necrosis factor alpha and interleukin 1 production. Immunology 1991:72:497-501.